Pittsburgh, PA, United States of America

Allan Tsung

This inventor holds 1 USPTO granted patent. Top assignees: The Feinstein Institutes for Medical Research, University of Pittsburgh. Active years: 2010.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Allan Tsung

Introduction

Allan Tsung is a notable inventor based in Pittsburgh, PA (US). He has made significant contributions to the field of medical research, particularly in the area of organ protection against ischemia reperfusion injury. His innovative work has the potential to impact the treatment of various medical conditions.

Latest Patents

Allan Tsung holds 1 patent for his invention titled "Use of HMGB1 for protection against ischemia reperfusion injury." This patent discloses methods and compositions for protecting an organ or tissue from inflammation and organ injury following ischemia, reperfusion, and trauma. The administration of an HMGB protein within a specific time frame is crucial for safeguarding the organ or tissue from injury.

Career Highlights

Throughout his career, Allan Tsung has worked with prestigious institutions, including the University of Pittsburgh and The Feinstein Institutes for Medical Research. His research has focused on advancing medical knowledge and improving patient outcomes through innovative solutions.

Collaborations

Allan Tsung has collaborated with esteemed colleagues such as Timothy R. Billiar and Mitchell P. Fink. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.

Conclusion

Allan Tsung's contributions to medical research and his innovative patent demonstrate his commitment to advancing healthcare solutions. His work continues to inspire future innovations in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…